Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Bioventus Inc. - Class A (BVS)
Company Research
Source: Yahoo! Finance
the earnings are expected to come in at -$0.05 per share. The full year 2024's revenue is expected to be $561.77 million and the earnings are expected to be -$0.15 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 10 Warning Signs with BVS. Over the past 90 days, revenue estimates for Bioventus Inc ( NASDAQ:BVS ) have increased from $542.77 million to $561.77 million for the full year 2024, and from $574.67 million to $601.63 million for 2025. During the same period, earnings estimates have declined from -$0.08 per share to -$0.15 per share for the full year 2024, and increased from $0.07 per share to $0.27 per share for 2025. In the previous quarter of 2024-06-30, Bioventus Inc's ( NASDAQ:BVS ) actual revenue was $151.22 million, which beat analysts' revenue expectations of $137.595 million by 9.9%. Bioventus Inc's ( NASDAQ:BVS ) actual earnings were -$0.37 per share, which missed analysts' earnings expectations of -$0.02 p
Show less
Read more
Impact Snapshot
Event Time:
BVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVS alerts
High impacting Bioventus Inc. - Class A news events
Weekly update
A roundup of the hottest topics
BVS
News
- MedRhythms Hires Joel Behnke as Chief Commercial Officer; Announces New Publications in Support of InTandem® [Yahoo! Finance]Yahoo! Finance
- Ultrasonic Scalpel Market to hit USD 5.3 billion by 2034, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners [Yahoo! Finance]Yahoo! Finance
BVS
Earnings
- 11/5/24 - In-Line
BVS
Sec Filings
- 1/14/25 - Form 4
- 1/13/25 - Form 144
- 1/13/25 - Form 4
- BVS's page on the SEC website